|
|
||||||||
Nuclear Medicine |
1 From the Division of Nuclear Medicine, Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007 (H.A.Z., A.K.A., A.A.M.Z.); and Larry R. Muenz and Associates, Gaithersburg, Md (L.R.M.). Received December 14, 2000; revision requested January 26, 2001; revision received April 25; accepted May 21. Address correspondence to H.A.Z. (e-mail: ziessmah@gunet.georgetown.edu).
PURPOSE: To establish normal gallbladder ejection fraction (GBEF) values for two sincalide (cholecystokinin [CCK]) infusion dose rates, 0.01 µg per kilogram of body weight infused for 3 minutes and 0.01 µg/kg infused for 60 minutes.
MATERIALS AND METHODS: Twenty healthy subjects were examined. GBEFs were calculated for the 3-minute infusion and for each 15-minute interval for the 60-minute infusion. Normal values were determined by using the mean ± 2 SDs and a more rigorous statistical analysis.
RESULTS: With the 3-minute infusion, GBEFs were significantly more variable than with the 45- and 60-minute values for the 60-minute infusion (P < .01, .002). With intervals including 95% of the population, the GBEF lower normal range was 16.8% for the 3-minute infusion but 31% and 41% for the 45- and 60-minute values, respectively. GBEFs of less than 35% were noted in six (30%) of 20 healthy subjects with the 3-minute infusion but in only one with the 60-minute infusion. Hepatobiliary ultrasonography was performed in six of seven subjects with GBEF of 36% or less, and US findings in all six were normal.
CONCLUSION: A 3-minute infusion of sincalide, 0.01 µg/kg, produces too variable a GBEF response to establish a clinically useful normal range. With 0.01 µg/kg infused for 60 minutes, clinically useful normal values were established at 45 and 60 minutes.
Index terms: Cholecystitis, 762.285 Gallbladder, function Gallbladder, radionuclide studies, 762.1216 Hormones
This article has been cited by other articles:
![]() |
M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Krishnamurthy, S. Krishnamurthy, and P. H. Brown Constancy and Variability of Gallbladder Ejection Fraction: Impact on Diagnosis and Therapy J. Nucl. Med., November 1, 2004; 45(11): 1872 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Ziessman, D. A. Jones, L. R. Muenz, and A. K. Agarval Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement J. Nucl. Med., August 1, 2003; 44(8): 1263 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Krishnamurthy, J. Cerulli-Switzer, N. Chapman, and G. T. Krishnamurthy Comparison of Gallbladder Function Obtained with Regular CCK-8 and Pharmacy-Compounded CCK-8 J. Nucl. Med., April 1, 2003; 44(4): 499 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Krishnamurthy, S. Krishnamurthy, H. A. Ziessman, and L. R. Muenz What Value Is Normal for Gallbladder Ejection Fraction, and How Is It Established? * Drs Ziessman and Muenz respond: Radiology, February 1, 2003; 226(2): 593 - 595. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |